ABSTRACT
NOTE: Please include 2 empty purple-top tubes and 2 empty green/gray-top tubes from each lot number collected for background contamination measurement.
Avian Influenza A H5N1
American Society for Microbiology (Reprinted from www.asp.org/policy/index.asp Accessed March, 2007)
Credits: Avian Influenza A H5N1
Subject Matter Expert, ASM
Michael J. Loeffelholz, Ph.D. D(ABMM) ViroMed Laboratories/LabCorp Minnetonka, MN
ASM Laboratory Protocol Working Group
Vickie Baselski, Ph.D. University of Tennessee at Memphis Memphis, TN
Roberta B. Carey, Ph.D. Centers for Disease Control and Prevention Atlanta, GA
Peter H. Gilligan, Ph.D. University of North Carolina Hospitals/Clinical Microbiology and Immunology Labs Chapel Hill, NC
Larry Gray, Ph.D. TriHealth Laboratories and University of Cincinnati College of Medicine Cincinnati, OH
Rosemary Humes, MS, MT (ASCP) SM Association of Public Health Laboratories Silver Spring, MD
Karen Krisher, Ph.D. Clinical Microbiology Institute Wilsonville, OR
Judith Lovchik, Ph.D. Public Health Laboratories, NYCDOH New York, NY
Chris N. Mangal, MPH Association of Public Health Laboratories Silver Spring, MD
Lahey Clinic Burlington, MA
Susan E. Sharp, Ph.D. Kaiser Permanente Portland, OR
Alice Weissfeld, Ph.D. Microbiology Specialists, Inc. Houston, TX
David Welch, Ph.D. Medical Microbiology Consulting Dallas, TX
Mary K. York, Ph.D. MKY Microbiology Consultants Walnut Creek, CA
Coordinating Editor:
James W. Snyder, Ph.D. University of Louisville Louisville, KY
Do NOT perform culture on specimens if avian influenza A H5N1 is suspected, unless performed under enhanced Biosafety Level (BSL) 3 laboratory conditions. Very few laboratories have the capability to operate under enhanced BSL 3 conditions. These instructions for culturing influenza A H5N1 may change if the epidemiological and clinical characteristics of the disease, and pathogenesis of the virus change.
